Delivery Order SPE2DB20D2104-SPE2DB25FMPMH
Award Date
4/28/25
Potential Completion Date
4/29/25
Potential Value
$14K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,537.06, is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a completion date of February 4, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,654.39, is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a completion date of March 18, 2025. The contract is a firm-fixed-price, non-set-aside procurement. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,798.72, is for the procurement of Ozempic 0.25-0.5 mg/dose pens. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,368.60, is for the delivery of Ozempic 0.25-0.5 mg/dose pens. It is a firm fixed-price contract with an ultimate completion date of April 16, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,008.55, is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a completion date of April 1, 2025. The contract is a firm-fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,270.06, is for the supply of Ozempic 0.25-0.5 mg/dose pens. The contract is a firm fixed-price, delivery order contract with a completion date of March 7, 2025. The award is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,684.73, is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a completion date of March 4, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,077.71, is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a completion date of June 27, 2024. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $57,707.36, is for the supply of Ozempic 0.25-0.5 mg/dose pens. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle to supply a wide...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $75,829.14, is for the delivery of Ozempic 0.25-0.5 mg/dose pens. The contract has an ultimate completion date of March 31, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...